Assaf-Harofeh Medical Center — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Assaf-Harofeh Medical Center appears in 51 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials51

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

51 shown

Metabolic Changes Associated With Weight Gain After Treatment of AchalasiaNCT07334639 · lead sponsor · 2026-01-15

NOT_YET_RECRUITING

Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis PatientsNCT07231900 · lead sponsor · 2025-11-10

NOT_YET_RECRUITING

Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular DiseaseNCT05349318 · lead sponsor · 2022-03-31

Influence of Circadian Clock on Hormonal, Metabolic, Neurocognitive Markers in Adolescents With and Without DiabetesNCT04054934 · lead sponsor · 2022-01-01

NOT_YET_RECRUITING

Develop a Multi-disciplinary Approach for a Personalized Prenatal Diagnostics and Care for Twin PregnanciesNCT04595214 · lead sponsor · 2020-12-21

RCT for Evaluation of Insulin Administration,While Using the iPORT SystemNCT04421001 · lead sponsor · 2020-10-01

Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes MellitusNCT04412200 · lead sponsor · 2020-06-01

Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided BiopsyNCT04064047 · lead sponsor · 2016-12-01

Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in HealthyNCT02923323 · lead sponsor · 2016-03-01

The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case SeriesNCT03594565 · lead sponsor · 2016-03-01

Glycemic Control and Treatment Satisfaction in Children With Type 1 Diabetes Using Insulin PumpsNCT03697369 · lead sponsor · 2015-05-31

Effect of Short Peripheral Electrical Stimulation (PES) on Blood GlucoseNCT02727790 · lead sponsor · 2014-07-01

Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-MyalgiaNCT02024568 · lead sponsor · 2013-12-01

Bronchoscopic Thermal Saline Ablation (BTSA) of Emphysematous Lung. A New Emphysema TherapyNCT01920321 · lead sponsor · 2013-02-01

The Effect of Guided Imagery in Children With Type 1 Diabetes Mellitus on Glucose Levels and on Glycemic ControlNCT01567254 · lead sponsor · 2012-04-01

Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus PatientsNCT01525784 · lead sponsor · 2012-02-01

The Effect of Vitamin D Supplementation on Arterial Stiffness in Diabetic PatientsNCT01500005 · lead sponsor · 2010-08-01

Obesity and Obstructive Sleep Apnea (OSA) in ChildrenNCT01135147 · lead sponsor · 2010-06-01

The Association Between High Risk Pregnancy and Sleep-disordered BreathingNCT01022619 · lead sponsor · 2010-01-01

Continuous Positive Airway Pressure Effect on Air Trapping in Chronic Obstructive Pulmonary Disease PatientsNCT01507844 · lead sponsor · 2009-11-01

Pharmacogenetic Effect on the Pharmacodynamics of GlibenclamideNCT01242137 · lead sponsor · 2009-10-01

Establishing First Trimester Markers for the Identification of High Risk TwinNCT02031393 · lead sponsor · 2009-09-01

Psychosocial Interventions in the Treatment of Youth With Type 1 Diabetes MellitusNCT01191866 · lead sponsor · 2009-09-01

Spirometry in Mechanically Ventilated Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00965029 · lead sponsor · 2009-09-01

The Prediction of Preeclampsia/Toxemia in Twin PregnancyNCT01255202 · lead sponsor · 2009-09-01

Effects of Transcranial Magnetic Stimulation (TMS) and Cognitive Training for Alzheimer PatientsNCT00909285 · lead sponsor · 2009-07-01

The Effect on Small Airways of Addition of Theophylline as Inducer of Histone Deacilase Activity for Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Treated With Inhaled Steroids and Long Acting Beta AgonistsNCT00893009 · lead sponsor · 2009-07-01

The Effect of Sildenafil on Sleep-Disordered Breathing in Obese Patients With Sexual DysfunctionNCT00893191 · lead sponsor · 2009-05-01

Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?NCT00867971 · lead sponsor · 2009-02-01

Effect of Diabetes Control on Outcome in Hospitalized Patients: A National Israeli StudyNCT00813475 · lead sponsor · 2009-01-01

CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer PatientsNCT00815555 · lead sponsor · 2008-12-01

Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?NCT00732966 · lead sponsor · 2008-09-01

Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)NCT00732407 · lead sponsor · 2008-09-01

The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and InflammationNCT00696982 · lead sponsor · 2008-06-01

Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast CancerNCT00496288 · lead sponsor · 2008-03-01

The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive ImpairmentNCT00544791 · lead sponsor · 2007-10-01

Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based StudyNCT00497666 · lead sponsor · 2007-08-01

The Effect of N-Acetylcystein on Quality of Life and Air Trapping During Rest and After ExerciseNCT00476736 · lead sponsor · 2007-05-01

ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug EffectsNCT00437775 · lead sponsor · 2007-01-01

The Effect of a Complementary Multi Disciplinary Program on Blood Pressure in Hypertensive PatientsNCT00409149 · lead sponsor · 2006-12-01

Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine WardNCT00464854 · lead sponsor · 2005-07-01

Hyperbaric Oxygen, Oxidative Stress, NO Bioavailability and Tissue OxygenationNCT00463671 · lead sponsor · 2003-12-01

Intracoronary Injection of Autologous Bone Marrow Cells in Patients With Chronic Heart Failure: Five Years Follow upNCT00933621 · lead sponsor · 2003-04-01

Active Surveillance for Prostate Cancer With Indolent FeaturesNCT00421265 · lead sponsor

Safety and Efficacy of Using GlucoSat Technology For Non-Invasive Glucose MeasurementNCT00451334 · lead sponsor

Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2NCT00473733 · lead sponsor

Hyperbaric Oxygen Therapy and Angiogenesis in Diabetic Patients With Foot UlcersNCT00475202 · lead sponsor

Closed-loop Medtronic 780G System in Youth With Type 1 DiabetesNCT05908708 · collaborator · 2023-06-01

Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia RiskNCT03036254 · collaborator · 2017-08-10

Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic PatientsNCT02337972 · collaborator · 2015-01-01

TMS Stimulation and Cognitive Training in Alzheimer PatientsNCT01168245 · collaborator · 2010-01-01

Drugs studied in this sponsor's trials

11 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Assaf-Harofeh Medical Center as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo3

losartan2

acetylcysteine1

aliskiren1

fluticasone propionate1

glyburide1

melatonin1

pregabalin1

placebo RxCUI 8375 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials losartan RxCUI 52175 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials acetylcysteine RxCUI 197 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial aliskiren RxCUI 325646 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial fluticasone propionate RxCUI 50121 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial glyburide RxCUI 4815 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial melatonin RxCUI 6711 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial pregabalin RxCUI 187832 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial sitagliptin RxCUI 593411 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial theophylline RxCUI 10438 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial valsartan RxCUI 69749 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor47

collaborator4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.